Live
- Gold prices likely to further come down with no near-term positive triggers
- Tough decision, but it's the right one: Southee on Test retirement
- After caste census, Dalits, tribals, poor will recognise their true strength: Rahul Gandhi
- Who was Birsa Munda, whose 'Ulgulan' declared the end of British rule in Jharkhand?
- Logistic firm Delhivery’s profit tanks over 80 pc in April-Sep period
- Five selected as Indian Rhodes Scholars for 2025
- Raj Thackeray releases MNS election Manifesto with a ‘key’ to implementing it
- COP29: 3 methodologies approved for issuing high-integrity carbon credits
- MP: Celebrations of Birsa Munda's birth anniversary begin in presence of Guv, CM in Shahdol
- NGT seeks details of waste to energy plants not complying with norms
Hyderabad: Pharma firm MSN Group offers free Corona medicine to corona warriors
Pharma firm MSN Group offers free Corona medicine to corona warriors
Pharmaceutical company MSN Group (MSN) has announced free Favilow tablets to corona warriors including doctors, nurses, journalists, police & sanitation personnel across 170 cities if tested Covid-19 positive
Hyderabad: Pharmaceutical company MSN Group (MSN) has announced free Favilow tablets to corona warriors including doctors, nurses, journalists, police & sanitation personnel across 170 cities if tested Covid-19 positive.
MSN will distribute free Favilow 200 mg tablets (Favipiravir) as an attempt to salute the selfless spirit of doctors, nurses, journalists, police & sanitation personnel. They can avail the benefit by providing the test report, doctor's prescription, and work ID at the customer care desk for free delivery of the drug, the company said in a statement.
Dr MSN Reddy, CMD, MSN Group, said "We want to express our solidarity with all the front-line fighters for displaying exemplary service during this pandemic situation. We feel as an organisation it is our responsibility to acknowledge & to service all the brave hearts," he said.
The drug 'Favipiravir' has been granted approval by DCGI for the treatment of suspected or laboratory-confirmed cases of Covid-19 in adults and children, hospitalised with mild to moderate symptoms of the disease.
